Investigators examine patients who demonstrated improvement after placebo injections and aimed to determine criteria to predict subsequent response.
Augmentation with guanfacine alongside cognitive remediation and social skills may be an effective intervention for patients with schizotypal personality disorder.
Strong religious activity and high polygenic schizophrenia risk scores are independent risk factors for religious delusions in schizophrenia and schizoaffective disorder.
Products covered under the Clozapine REMS program include Clozaril (HLS Therapeutics), Fazaclo (Jazz), and Versacloz (TruPharma), in addition to all generic versions.
A negative association between number of cigarettes per day and quality of life was observed in patients with psychosis.
Peer victimization may be an important modifiable factor in improving the developmental course among children.
Researchers investigated subgroup responses to long-acting injectable medications haloperidol decanoate and paliperidone palmitate.
Examination of raw data does not show a multi-modal distribution of immune parameter data in patients.
Clinicians should be discerning when evaluating meta-analyses of schizophrenia add-on therapies such as statins and antidepressants.
Investigators confirmed that people with schizophrenia have higher levels of antibodies to some but not all Epstein-Barr virus proteins, which indicates an aberrant response to Epstein-Barr virus infection that may be a factor in the immunopathology of schizophrenia and related disorders.